Study Stopped
The sponsor requested an early termination of the study following insufficient engagement of subjects beyond 12 months of follow-up (initial follow-up was 18 months).
Interest in the Medium Term of an Infrared Reflexotherapy on Overweight or Class I Obese People
REFLEX-IR
1 other identifier
interventional
87
1 country
1
Brief Summary
The study aim is to Assess the Effect of an IR Reflexotherapy on Overweight and Class I Obese People.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 18, 2013
CompletedFirst Submitted
Initial submission to the registry
November 26, 2013
CompletedFirst Posted
Study publicly available on registry
December 3, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 28, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 28, 2016
CompletedDecember 8, 2022
December 1, 2022
2.3 years
November 26, 2013
December 6, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Weight changes after 12 months compared to a dietary care (associated with physical activity advice) dispensed by a professional.
12 months
Secondary Outcomes (12)
Effect of infrared (IR) reflexotherapy on weight changes.
3, 12 and 18 months
Effect of IR reflexotherapy combined with a dietary care (and physical activity advises) dispensed by a professional on the weight changes.
3, 12 and 18 months.
Effect of infrared (IR) reflexotherapy on waist size.
3, 12 and 18 months
Effect of IR reflexotherapy combined with a dietary care (and physical activity advises) dispensed by a professional on the waist siez.
3, 12 and 18 months.
Effect of infrared (IR) reflexotherapy on dietary habits.
3, 12 and 18 months
- +7 more secondary outcomes
Study Arms (3)
Dietary care
ACTIVE COMPARATORTreatment is composed of a dietary care (with advices on physical activity) given by a professional (dietician of the Nutrition Department of the Institut Pasteur de Lille).
IR reflexotherapy + dietary care
EXPERIMENTALTreatment is composed of : * IR reflexotherapy sessions given by a trained professional ; * dietary care (with advices on physical activity) given by a professional (dietician of the Nutrition Department of the Institut Pasteur de Lille).
IR Reflexotherapy
EXPERIMENTALTreatment is composed of IR reflexotherapy sessions given by a trained professional.
Interventions
18 IR reflexotherapy sessions : * Once a week for 12 weeks at the beginning of the study * Once a week for 3 weeks, 9 months after the beginning of the study * Once a week for 3 weeks, 15 months after the beginning of the study
Dietary consultation 1, 2, 3, 6, 9, 12, 15 and 18 months after the beginning of the study
Eligibility Criteria
You may qualify if:
- BMI between 27 and 35 kg/m2 (included),
- Aged 30 to 60 years old (included),
- Stable weight: no variation of 3 kg in the las 3 months,
- Signed the consent form,
- Able to follow the study,
- Health insured.
You may not qualify if:
- History of coronary disease (in the last 6 months),
- Progressive illness at the time of the study (cancer, neurodegenerative disease...),
- Diabetics (treated or not),
- Fasting blood total cholesterol equal or over 2.5 g/L (treated or not),
- Fasting blood triglycerides equal or over 2.0 g/L (treated or not),
- Fasting blood glucose equal or over 1.26 g/L,
- Peripheral neuropathy (polyneuritis, diabetic neuropathy) or central neuropathy (hemiplegia),
- Infectious cutaneous condition or allergies (to the contact point of the device),
- History of stroke,
- Severe heart disease,
- Epilepsy,
- Reduced motility,
- Diagnosed eating disorder,
- Followed a diet in the last 90 days in order to lose weight,
- Took weight loss assistance drug (Orlistat) in the last month or is likely to take one during the study,
- +12 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institut Pasteur de Lillelead
- Luxomedcollaborator
Study Sites (1)
NutrInvest - Institut Pasteur de Lille
Lille, Nord, 59019, France
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Michel LECERF, MD
Institut Pasteur de Lille
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical doctor specialized in endocrinology and metabolic diseases
Study Record Dates
First Submitted
November 26, 2013
First Posted
December 3, 2013
Study Start
October 18, 2013
Primary Completion
January 28, 2016
Study Completion
January 28, 2016
Last Updated
December 8, 2022
Record last verified: 2022-12